TITAN PHARMACEUTICALS: Titan Pharmaceuticals Partners With Southside To Further Expand Specialty Pharmacy Network For Probuphine®
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced that it has executed a pharmacy services agreement with Southside Specialty Pharmacy, further expanding access to treatment with Probuphine (buprenorphine) implant, Titan's novel maintenance treatment for Opioid Use Disorder (OUD) in eligible patients. Read More »
Alerts Sign-up